MedPath
HSA Approval

CO-TRIMEXAZOLE SUSPENSION

SIN00583P

CO-TRIMEXAZOLE SUSPENSION

CO-TRIMEXAZOLE SUSPENSION

April 29, 1988

BEACONS PHARMACEUTICALS PTE. LTD.

BEACONS PHARMACEUTICALS PTE. LTD.

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantBEACONS PHARMACEUTICALS PTE. LTD.
Licence HolderBEACONS PHARMACEUTICALS PTE. LTD.

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

SUSPENSION

ORAL

Medical Information

J01EE01

sulfamethoxazole and trimethoprim

Manufacturer Information

BEACONS PHARMACEUTICALS PTE. LTD.

BEACONS PHARMACEUTICALS PTE LTD

Active Ingredients

TRIMETHOPRIM

40 mg/5 ml

Trimethoprim

SULPHAMETHOXAZOLE

200 mg/5 ml

Sulfamethoxazole

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

CO-TRIMEXAZOLE SUSPENSION - HSA Approval | MedPath